Single-nucleotide polymorphisms (SNPs) have the potential to be particularly useful as markers for monitoring of chimerism after stem cell transplantation (SCT) because they can be analyzed by accurate and robust methods. We used a twophased minisequencing strategy for monitoring chimerism after SCT. First, informative SNPs with alleles differing between donor and recipient were identified using a multiplex microarray-based minisequencing system screening 51 SNPs to ensure that multiple informative SNPs were detected in each donor-recipient pair. Secondly, the development of chimerism was followed up after SCT by sensitive, quantitative analysis of individual informative SNPs by applying the minisequencing method in a microtiter plate format. Using this panel of SNPs, we identified multiple informative SNPs in nine unrelated and in 16 related donor-recipient pairs. Samples from nine of the donor-recipient pairs taken at time points ranging from 1 month to 8 years after transplantation were available for analysis. In these samples, we monitored the allelic ratios of two or three informative SNPs in individual minisequencing reactions. The results agreed well with the data obtained by microsatellite analysis. Thus, we conclude that the two-phased minisequencing strategy is a useful approach in the following up of patients after SCT.
Introduction
Allogeneic stem cell transplantation (SCT) is extensively used to treat patients with hematological malignancies as well as nonmalignant conditions, such as aplastic anemia, immunodeficiency syndromes and hemoglobinopathies. 1 Distinguishing between residual host hematopoiesis and donor hematopoiesis has become a valuable tool to monitor the engraftment process. Determination of the proportion of donor and host cells in the period after SCT permits early distinction between successful engraftment and failure in the engraftment process. 2 In nonmyeloablative SCT monitoring, chimerism status provides guidance for therapeutic interventions. 3, 4 Analogously, donor lymphocyte infusions (DLI) used to treat disease relapse in chronic myeloid leukemia may be followed up kinetically by chimerism analysis. 5 The monitoring of chimerism may also permit early identification of patients with risk of disease recurrence. 6, 7 Thus, there is an increasing demand of reliable methods to monitor the success of engraftment in clinical routine laboratories. Fluorescent in situ hybridization (FISH) with X-and Ychromosome-specific probes has been used to demonstrate chimerism after SCT. However, this method is not universally applicable as X-and Y-chromosome-specific FISH is applicable only for sex-mismatched transplantation. 8, 9 Polymorphic genetic markers that allow distinction between the donor and recipient cells based on allelic differences between the two cell populations are useful tools for determining hematopoietic chimerism after SCT or DLI. 1 Preferably, the proportion of recipient cells after SCT should be assessed quantitatively to allow prognostic evaluation. At present, most laboratories use PCR amplification of the multiallelic variable number of tandem repeat (VNTR) or short tandem repeat (STR) marker systems for this purpose. 10, 11 Recently, short insertion/ deletion polymorphisms detectable by quantitative real-time PCR were introduced as alternatives to VNTR or STR markers for monitoring SCT. 12 Single-nucleotide polymorphisms (SNPs) that occur on average at every 1.3 kb in the human genome are the most common type of genetic variation. 13 Since most SNPs are biallelic with alleles that differ from each other only at a single nucleotide, they are easier to genotype than the VNTR and STR markers that exhibit length polymorphism and thus require genotyping methods with a size separation step. The SNPs are advantageous as markers for monitoring chimerism after SCT, where it is beneficial to obtain quantitative data on the proportion between the alleles representing the donor and recipient cells. During PCR, both alleles of an SNP are amplified with equal efficiency, as opposed to VNTR and STR alleles, where preferential amplification of the shorter allele and other PCR-related artefacts such as 'stutter peaks' may cause errors to the quantification and even risk of mistyping. [14] [15] [16] [17] [18] [19] [20] [21] Moreover, SNP alleles can be accurately quantified in the PCR product using primer-extension-based methods, 22 as was recently demonstrated in a proof of principle study for SCT monitoring by the pyrosequencing technique using a panel of 14 SNPs. 23 In a previous study, we have shown that analysis of a panel of SNPs by PCR and solid-phase minisequencing in a microtiter plate format allows identification of individuals for paternity testing and forensics, as well as for quantification of the SNP alleles in mixed samples containing DNA from more than one individual. 24 The assay allows sensitive, quantitative detection of minority point mutations present as less than 1% in a cell sample. 22, 25, 26 In the current study we propose a two-phased minisequencing primer extension strategy for monitoring hematopoietic chimerism after allogeneic SCT. First, informative SNPs are identified using a multiplex microarray-based minisequencing system that screens 51 SNPs to ensure that multiple informative SNPs are detected in any donor-recipient pair. Secondly, the development of chimerism is followed up after SCT by sensitive quantitative analysis of individual, informative SNPs, applying the minisequencing method in the microtiter plate format. Using the panel of 51 SNPs, we identified sets of informative SNPs in 25 pairs of SCT donors and patients with hematological malignancies. In nine of these cases, the outcome of SCT was followed up with quantitative minisequencing over time periods ranging from 1 month to several years.
Materials and methods

Patients, donors and samples
Samples from 25 patients who underwent SCT or bone marrow transplantation (BMT) during the period 1994-2001 at Uppsala University Hospital were analyzed. The patients suffered from malignant hematological disorders, including chronic myeloid leukemia (CML, n ¼ 14), acute myeloid leukemia (AML, n ¼ 4), acute lymphoblastic leukemia (ALL, n ¼ 3), chronic lymphoblastic leukemia (CLL, n ¼ 2), myelodysplastic syndrome type 3 (MDS type 3, n ¼ 1), diffuse large B-cell lymphoma (n ¼ 1) and kidney cancer (n ¼ 1). The patients were treated according to the National Swedish Treatment Guidelines for their respective disease and the samples analyzed were drawn for chimerism analysis with informed consent obtained from the patients. The 25 donors were either human leukocyte antigen (HLA)-matched siblings of the patients (n ¼ 16) or HLA-matched unrelated individuals (n ¼ 9). Blood or bone marrow samples were collected from the donors and patients prior to transplantation and from the patients at intervals ranging from 1 month to 8 years after SCT. DNA was prepared according to a standard salting-out method. 27 A pooled sample containing an equal amount of DNA from 99 Swedish men was used to determine the SNP allele frequencies of the markers. DNA from 20 individuals from the same group of men was used for optimizing the genotyping on microarrays, and for preparing mixed samples with known amount of DNA of different genotypes for quantification standard curves. 24, 28 SNPs A total of 60 SNPs were retrieved from the dbSNP database (http://www.ncbi.nlm.nih.gov/SNP). The SNPs were selected from different chromosomal regions and to have allele frequencies of 0.3-0.7 in Caucasians. The sequences flanking the SNP were analyzed with the BLAST program (http:// www.ncbi.nlm.nih.gov/BLAST/) to ensure one unique hit in the genome. The RepeatMasker program (http://ftp.genome.washington.edu/cgibin/RepeatMasker) was used to identify repetitive elements. Table 1 provides detailed information about the SNPs selected for the panel.
Statistical evaluation of the SNPs
Monte Carlo simulation 29 was used to determine the most probable number of informative SNPs in unrelated and related donor-recipient pairs. For the SNPs with a frequency over 5% for the minor allele, Hardy-Weinberg equilibrium was assessed by comparison of the observed and expected genotype frequencies using the w 2 test with one degree of freedom.
Oligonucleotides
PCR primers were designed, using the Oligo Primer Analysis Software v.6. 65 (Molecular Biology Insights Inc., Cascade, CO, USA), to have the nucleotides A or C at their 3 0 -end to avoid 3 0 -primer dimers. One PCR primer of each pair to be used in the 
PCR amplification
For genotyping using microarrays, multiplex PCRs with three to nine primer pairs in each reaction were performed with the primer concentrations 0.2.-0.3 mM. In all, 6 ng of DNA and 0.03 U/ml AmpliTaq Gold DNA polymerase (Applied Biosystems, Forster City, CA, USA), 3 mM MgCl 2 and 200 mM dNTPs were used per 50 ml reaction. The cycling conditions were 941C for 10 min, 941C for 1 min, 551C for 1 min, 721C for 1.5 min for 35 cycles, and a final extension at 721C for 7 min in a thermal cycler (PTC-225, MJ Research, Waterton, MA, USA) For genotyping using microtiter plates, the SNPs were amplified individually using 10 ng of genomic DNA, 0.2 mM of the 5 0 biotinylated PCR primer, 1.0 mM of the nonbiotinylated primer, 0.01 U/ml of AmpliTaq Gold DNA polymerase (Applied Biosystems, Forster City, CA, USA), 1.5 mM MgCl 2 and 200 mM dNTPs in 100 ml of PCR buffer. The cycling conditions were 941C for 10 min, 941C for 30 s, 551C for 30 s, 721C for 45 s for 35 cycles, and a final extension at 721C for 7 min in a thermal cycler (PTC-225, MJ ResearchWaterton, MA, USA). The PCR primer sequences are available from the authors upon request.
Preparation of microarrays
The microarrays were prepared by covalent coupling of the capturing oligonucleotides, complementary to the tag-sequence of the minisequencing primers, on CodeLink TM Activated Slides (Amersham Biosciences, Uppsala, Sweden) in an 'array of arrays' conformation essentially as described previously. 30, 31 For more details on preparation of the microarrays, see the Appendix 'Methods in Focus'.
Genotyping on microarrays
Pooled multiplex PCR products from each sample were concentrated using a Microcon YM-30 device (Millipore Corporation, Bedford, MA, USA) according to the manufacturer's instructions and treated with Exonuclease I and shrimp alkaline phosphatase (USB Corporation, Cleveland, Ohio, USA) to inactivate excessive PCR reagents. Each minisequencing reaction mixture contained the enzyme-treated PCR products, the tagged minisequencing primers, four fluorescently labeled dideoxynucleotides (Perkin-Elmer Life Sciences, Boston, MA, USA) and Thermo Sequenase TM DNA Polymerase (Amersham Biosciences, Uppsala, Sweden), and cyclic minisequencing reactions were performed in a Thermal Cycler PTC-225 (MJ Research, Watertown, MA, USA) essentially as described previously. 30 The arrayed slides carrying the capturing oligonucleotides were preheated to 421C in a custom-made aluminum reaction rack with a silicon rubber grid forming 14 separate reaction chambers on each slide. 32 The products of the cyclic minisequencing reactions were added to the reaction chambers on the slide, allowed to hybridize for 2.0-2.5 h at 421C, after which the slides were washed and dried by centrifugation. Fluorescence signals were detected and quantified with a ScanArray s 5000 instrument and QuantArray s analysis 3.1 software (Perkin-Elmer, Life Science, Boston, MA, USA) and the genotypes were assigned with a Microsoft Excel TM macro. The minisequencing and hybridization reaction conditions are given in full detail in the Appendix 'Methods in Focus'.
Genotyping using solid-phase minisequencing
Aliquots of the individual biotinylated PCR products were captured in streptavidin-coated microtiter plate wells (Combiplate 8, Labsystems, Helsinki, Finland), after which the nonbiotinylated strand of the PCR products were removed by alkaline denaturation followed by washing. Minisequencing reaction mixtures containing AmpliTaq DNA polymerase (Applied Biosystems, Foster City, CA, USA), the appropriate 3 H-labeled deoxynucleotide (Amersham Biosciences, Uppsala, Sweden) and detection primer were added to the wells, and the reactions were allowed to proceed for 10 min at 501C. 24 After washing, the primers were released by treatment with an alkaline reagent and the incoroprated [ 
Determination of SNP allele fractions and proportion of donor cells
For each SNP, a heterozygous sample where the two SNP alleles are present in equal amounts was used as reference sample for calculating the proportion of the SNP allele fraction in the pooled sample and for chimerism analysis. The proportion of donor cells in the follow-up samples was determined based on the allele fraction of the unique SNP that distinguishes the donor and the recipient in each pair. For more details on the calculations, see the Appendix 'Methods in Focus'.
Reference method
A set of 14 polymorphic STR markers were analyzed to identify informative markers in each donor-recipient pair, and to subsequently determine the degree of chimerism in the followup samples. The STRs were chosen from the Weber set 6 (Cooperative Human Linkage Center) of STR markers 33 and comprised the markers D3S1768, D3S2398, D5S820, D7S1826, D9S1118, D10S677, D12S395, D13S796, D14S617, D15S659, D15S642, D16S539, D19S247 and D19S246. The STR markers were amplified by PCR from 25 ng genomic DNA using forward primers fluorescently labeled with TET, HEX or 6-FAM in a total volume of 15 ml. Separation of the PCR products and fluorescent detection were performed on a 4% denaturing polyacrylamide gel on an ABI Prism TM 377 DNA sequencer (Applied Biosystems, Foster City, CA, USA) and analyzed using the GeneScan TM and Genotyper TM programs. The STR allele fractions were calculated using the peak areas from the electropherogram.
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Results
Design of the SNP marker panel
We developed a microarray-based minisequencing system for genotyping a panel of SNPs that allows distinction between donor and recipient cells after allogeneic SCT. Using public databases, we selected 60 SNPs at different genomic location. SNPs validated by the SNP consortium to be polymorphic in the Caucasian population were primarily selected. The selected SNPs were confirmed experimentally to be polymorphic in the Swedish population by analyzing a pooled DNA sample representing 99 Swedish individuals using solid-phase minisequencing in a microtiter plate format. Despite the careful in silico selection of the SNPs to be included, nine of them had to be discarded from the panel because they did not appear to be polymorphic in our population (n ¼ 4) or due to PCR failure (n ¼ 5). The determined allele frequencies are similar, although not identical, to those given in dbSNP ( Table 1 ). The allele frequencies for the minor alleles range from 0.14 to 0.50, with a mean value of 0.38. According to Monte Carlo simulation 29 this panel of SNPs will contain at least 10 informative markers in all unrelated donor-recipient pairs, and in siblings at least five informative markers will be identified with a probability of 99.5%.
Microarray-based SNP genotyping
A tag-array genotyping system, based on cyclic fluorescent minisequencing primer extension reaction in solution 30 followed by capture of the products of the cyclic minisequencing reactions on tag-microarrays, 34 was designed for genotyping the panel of 51 SNP markers using primers for both strands of the DNA. The system was initially established by analyzing DNA from 20 control individuals. For 46 of the 51 SNPs, analysis of both polarities of the DNA produced signal ratios according to which the same genotype was assigned for each sample. In the remaining SNPs only one of the polarities gave unequivocal genotyping results. Figure 1 shows a scanned image of one microarray slide on which 14 samples were analyzed and the images of a 'subarray' with one sample, obtained upon scanning the slide at four different wavelengths.
Informative SNPs in stem cell donor-recipient pairs
The microarray-based minisequencing system was applied to genotype DNA samples from 25 patient samples obtained prior to SCT and from the corresponding donors, of which nine were unrelated and 16 were siblings to the respective recipient. This analysis identified 8-19 informative SNPs (average 12) for the unrelated donor-recipient pairs, and 4-10 informative SNPs (average six) for the related donor-recipient pairs. A fluorescence image (TAMRA-ddC) of a tag-microarray slide scanned after capture of the fluorescent minisequencing products for the SNP marker panel. A 'subarray', scanned at four different wavelengths for detecting signals from Texas Red-ddA, TAMRA-ddC, R110-ddG and Cy5-ddU is enlarged. The rainbow color scale corresponds to the signal intensities where blue represent a low signal and white represent a saturated signal.
Figure 2
Histogram showing the number of informative SNP markers identified in unrelated (1-9) and related (10-25) donorrecipient pairs. The black boxes represent pairs with a heterozygous recipient and a homozygous donor, dark gray boxes represent a homozygous recipient and a heterozygous donor and light gray boxes represent disparate homozygotes.
Monitoring chimerism by SNP analysis M Fredriksson et al
Quantification of SNP alleles Figure 3 shows examples of standard curves generated for three SNPs, rs13841 for which the recipient was homozygous and the donor was heterozygous (panel a), and rs715463 for which the recipient was heterozygous and the donor was homozygote (panel b) and rs714195 that displayed disparate homozygote genotypes between recipient and donor (panel c). DNA from individuals of known genotype was mixed at varying concentrations to determine the sensitivity of detecting the SNP allele present as a minority in a sample. The ratio between the [ 3 H]dNTPs incorporated in the minisequencing reactions were plotted on a logarithmic scale as a function of the of the ratio between the two sequences present in the original mixture ( Figure 3 ). As can be seen, in all three cases, the standard curves are linear and less than 1% of the minority allele can be detected.
Quantification of chimerism after SCT
At least two of the informative SNPs identified using the microarray system were analyzed individually using solid-phase minisequencing in the microtiter plate format in each of the follow-up samples. The informative SNPs yielding the largest differences in signal ratios between homozygous and heterozygous genotypes, and SNPs that were informative in more than one case were selected for the follow-up analysis. Table 2 presents the ratio (R-value) between the counts per minute (cpm) values measured for the two alleles. The R-values differ between SNPs depending on the nucleotide sequence following the SNP, because in some cases more than one [ 3 H]dNTP will be incorporated (rs715710, rs714195, rs713503, rs715447), and because the specific activities of the [ 3 H]dNTPs used affect the R-value. There are also sequence-dependent differences in the levels of misincorporation of [ 3 H]dNTPs by the DNA polymerase. Particularly for homozygous genotypes, small differences in mis-incorporation rates between SNPs may cause significant differences in the R-values. To correct for the factors described above, the ratios between signals measured in the follow-up samples after the minisequencing reaction, given in Table 2 , were normalized with respect to the corresponding ratio from a heterozygous sample, which, with two exceptions, was the sample from either the donor or the recipient. Since the two SNP alleles are present in equal amounts in a heterozygous sample, the allele fractions present in a mixed sample can be accurately determined. The percentage of donor cells in the follow-up samples was calculated with the aid of the fraction of the unique SNP allele in each donor-recipient pair. For each analyzed SNP, the percentage of cells from the donor was plotted over time for the follow-up samples ( Figure 4 ). As can be seen in Figure 4 , almost identical percentage of donor cells was obtained in a sample with all SNP markers used in this calculation.
Monitoring chimerism by SNP analysis in post-SCT samples
Follow-up samples taken 1 month up to 8 years after SCT from nine of the patients were available for analysis (Figure 4) . Case 3, a CML patient with a molecular and cytogenetic relapse was Table 2 Minisequencing signal ratio for the informative SNPs analyzed in the follow-up samples 
Figure 3
Solid-phase minisequencing standard curves for quantification of known DNA mixtures for three different SNPs, rs13841 for which the recipient was homozygous and the donor was heterozygous (a), and rs715463 for which the recipient was heterozygous and the donor was homozygote (b) and rs714195 that displayed disparate homozygote genotypes between recipient and donor (c). The mean cpm allele1 /cpm allele2 ratio in three parallel minisequencing reactions is plotted on a log scale as a function of the proportion between the two sequences in the original mixtures. The arrows indicate the cpm allele1 / cpm allele2 ratio obtained when the two samples in the mixture were analyzed separately.
Monitoring chimerism by SNP analysis M Fredriksson et al treated with three DLI infusions. Despite DLI, no shift to donor chimerism could be detected. In contrast, Case 23, also a CML patient with molecular and cytogenetic relapse, converted to full donor chimerism after two DLI infusions. In two of the patients, Case 12 and 25, the percentage of donor cells had reached the level of the donor at the first time point analyzed 9 and 12 months post-SCT, respectively. Chimerism analysis of Case 15, transplanted for chronic myelomonocytic leukemia, showed that the percentage of donor cells represented only about 20% of the total at 8 and 10 months post-SCT. This patient required a new transplantation from the same donor 12 months after the first SCT before reaching full donor chimerism. Case 24, diagnosed with chronic myeloid leukemia, had a molecular relapse almost 8 years after transplantation and was then treated with the tyrosine kinase inhibitor Imatinib. 35 Remarkably, Imatinib not only decreased expression of BCR-ABL mRNA (data not shown) but also in the only sample analyzed after this treatment the percentage of donor cells almost reached the level of the donor. Case 13, a CLL patient receiving a reducedintensity conditioning SCT, showed a pattern of mixed chimerism with predominance of donor cells after an initial gradual increase during a follow-up period from 1 to 27 months after transplantation. Case 21, a Philadelphia-positive ALL patient, received an SCT from a related donor and also showed a gradual increase in donor cells after tapering down immunosupression and reached full donor chimerism 9 months post-SCT. In Case 10, a pattern of mixed chimerism could be seen in the two follow-up samples that were available for analysis (Figure 4 ).
Comparison with STR quantification
To validate the results obtained by the minisequencing assay in the clinical situation, we compared our results with the data obtained from the more widely used STR analysis. As can be seen in Figure 4 , our results obtained by minisequencing compare well with the percentage of donor cells determined in the same samples using STR markers. Thus, we conclude that our method, based on SNP markers, is an accurate tool for quantification of chimerism after SCT.
Discussion
In this study, we present a universal two-phased minisequencing strategy for monitoring hematopoietic chimerism after allogeneic SCT using SNP markers. Initially, DNA samples from the stem cell donor and the recipient are screened using a microarray-based multiplex genotyping system to identify SNPs with genotypes that differ between donor and recipient. The identified informative SNPs are then used as markers in quantitative minisequencing analysis of recipient samples at multiple time points after allogeneic SCT.
We have established the microarray-based minisequencing system for a panel of 51 SNP markers with an average minor allele frequency of 0.38 in our population. The SNPs were selected from different chromosomes, or at long distances from each other on the same chromosome, to ensure that the marker alleles are inherited independently of each other. The likelihood of identifying at least one informative SNP with genotypes that differ between a cell donor and a recipient in unrelated donorrecipient pairs as well as in siblings is essentially 100% with this SNP panel. From this panel, at least five informative SNPs will be identified in siblings, and at least 10 informative SNPs will be identified in unrelated individuals with a probability of 99.5%. Our microarray-based genotyping system based on 51 SNPs is thus superior for identifying 'diagnostic' SNP markers for the follow-up of SCT to the previously described panel of 14 SNPs analyzed by the pyrosequencing assay 23 or a recently described set of seven SNPs analyzed by real-time PCR, which was informative only in 67% of sibling pairs. 36, 37 The 'array of arrays' format with multiple 'subarrays' on each slide 32 that we use facilitates multiplexed genotyping of the whole panel of 51 SNPs in samples from seven donor-recipient pairs on a single microscope slide. In our study, we identified multiple informative SNPs in each of the 25 donor-recipient pairs analyzed, and the numbers of informative SNPs identified experimentally were in good agreement with the statistically predicted numbers. The determined genotypes of all markers with minor genotype frequencies over 5% conferred to HardyWeinberg expectations. These two results represent indirect evidence for the accuracy of our genotyping system.
In addition to being a powerful tool for distinguishing the cells originating from a stem cell donor in blood samples from the recipient, the SNP panel that we describe here would also be a powerful tool for paternity testing and for forensic identification of individuals. In paternity testing, the exclusion probability of the SNP panel would be over 99.99% when the genotypes of both the mother and child are known. The probability of a random match between unrelated individuals using our panel of 51 markers is virtually nonexisting (below 10 À15 ). 38 The SNP marker panel described here has a similar exclusion power as the best STR marker systems that are currently used in forensic and paternity analyses. 38 Today, multiplex genotyping of SNPs on microarrays requires assay design and production of microarrays in house, but informative microarray panels applicable both for assessing hematopoietic chimerism and for forensic purposes will probably be available from commercial suppliers in the near future.
In earlier studies, we have shown that the microarray-based minisequencing system with four color fluorescence detection allows accurate quantitative detection of SNP alleles present as 2-5% in a DNA sample, 30 while as little as 1% of a minority sequence can be detected by minisequencing in individual microtiter plate wells using 3 H-labeled dNTP. 25, 26 Both the pyrosequencing and the minisequencing methods take advantage of the high sequence specificity of the primer extension reactions catalyzed by the DNA polymerases, and therefore both methods are accurate and sensitive for quantitative SNP analysis. 39 In a recent study, reproducible detection of 5% of donor cells in recipient samples after allogeneic SCT using the pyrosequencing method was reported. 23 In our study, the detection threshold for assessing hematopoietic chimerism after SCT using the microtiter plate format of the minisequencing method was 1% of the informative SNP allele. Since both minsequencing and pyrosequencing rely on the incorporation of dNTPs that are identical to the natural dNTPs, they are more 
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methods based on fluorescent ddNTPs. However, pyrosequencing requires multiple enzymes for the indirect bioluminscence signal detection procedure, and therfore the sensitivity of minisequening, in which the incorporated 3 Hlabeled dNTP are directly measured is better than that of pyrosequencing. The measured minisequencing or pyrosequencing signals corresponding to the two SNP alleles directly reflect the relative amounts of two allelic variants in a mixed sample. This uncomplicated option for quantification is an advantage of the primer extension approach, which can be viewed as competitive PCR analysis in contrast to kinetic real-time PCR analysis, in which a calibration curve is required for both alleles to determine their relative amount in a mixed sample. An advantage of real-time PCR, however, is the low detection limit for mixed chimerism after SCT, reported to be 0.1% both for SNP alleles 36, 37 and for biallelic short insertion/deletion polymophisms. 12 However, quantification in the lower range is imprecise and many studies based on quantitative PCR report significant variability 40, 41 and typically allows quantification with a precision that may vary by a factor of two. 42 In our study, we found that the SNP panel analyzed in a multiplexed microarray format ensures that several informative SNP markers are identified in each donor-recipient pair and the assay in a microtiter plate format provides accurate quantification of the individual SNP alleles. We conclude that the twophased minisequencing strategy presented here represents a sensitive and reliable alternative for the quantitative assessment of mixed chimerism after allogeneic SCT.
Appendix: Method in focous Assay characteristics
In the primer extension reaction (minisequencing), a DNA polymerase is used to extend a detection primer, which anneals immediately adjacent to a single-nucleotide polymorphism (SNP), with labeled nucleotide analogues. 22, 43 For solid-phase minisequencing in the microtiter plate format, a DNA fragment containing the SNP is amplified using one biotinylated and one nonbiotinylated PCR primer. The biotinylated PCR products are captured on streptavidin-coated microtiter plate wells and denatured. The nucleotides at the SNP site are identified in the immobilized DNA by primer extension reactions, in which a DNA polymerase incorporates a 0 tag sequences are used, and the products of the cyclic minisequencing reactions performed in solution are captured on microarrays carrying oligonucleotides complementary to the tag sequences. The incorporated ddNTPs are detected by scanning the microarray slide at four different wavelengths. 30 In both assay formats, the ratio (R) between the radioactive or fluorescent signals corresponding to the two SNP alleles are used for assigning the genotypes of the SNPs and for quantitative determination of the SNP allele fractions in mixed samples.
Here, we present a two-phased minisequencing strategy for monitoring chimerism after stem cell transplantation (SCT). First, informative SNPs with alleles differing between donor and recipient are identified using the multiplex microarray-based minisequencing system. This format allows the analysis of 12 samples and two controls for up to 60 SNPs in duplicate in both polarities of the DNA. Secondly, the development of chimerism is followed up after SCT by sensitive, quantitative analysis of individual informative SNPs by the minisequencing method in the microtiter plate format. This format allows duplicate analysis of two SNPs in 12 samples or three SNPs in eight samples per 96-well microtiter plate.
Protocol
DNA preparation
DNA is extracted from the samples according to a standard procedure. The DNA concentration is measured spectrophotometrically at 260 nm and the isolated DNA is stored at À201C.
SNPs
The SNPs to be genotyped should be selected from different chromosomal locations to ensure that they are inherited independent of each other. To be of maximum informative content they should have allele frequencies near 0.5 (range 0.3-0.7) in the population of interest. The SNPs can be validated by analyzing pooled DNA samples using quantitative minisequencing in a microtiter plate format as described below for chimerism analysis.
PCR amplification
For the microarray-based genotyping, 6 ng of genomic DNA is amplified in multiplex PCR reactions with up to 10 primer pairs in each reaction or in single PCRs according to a standard PCR protocol, for example, with 0.03 U/ml of AmpliTaq Gold DNA polymerase, 3 mM MgCl 2 , 200 mM dNTPs and primer concentrations ranging from 0.2 to 0.3 mM in 50 ml of buffer supplied with the enzyme.
For genotyping in microtiter plates, the SNP markers are amplified in individual reactions using 10 ng genomic DNA, 0.2 mM of the 5 0 biotinylated PCR primer, 1.0 mM of the nonbiotinylated primer according to a standard PCR protocol, for example, with 1.0 U AmpliTaq Gold DNA polymerase, 1.5 mM MgCl 2 , 50 mM KCl, 10 mM Tris-HCl, pH 8.3, 200 mM dNTPs, in a final volume of 100 ml.
Preparation of microarrays
The capturing oligonucleotides, complementary to the tag sequence of the minisequencing primers, are covalently attached via their 3 0 -NH 2 groups to CodeLinkt activated slides according to the manufacturer's instructions. This chemistry has been shown to be optimal for our method. 44 The oligonucleotides are immobilized in duplicate spots of 150 mm in diameter to form 14 subarrays per slide in an 'array of arrays' conformation 32 using a contact printing robot such as a ProSys 5510A instrument with Stealth Micro Spotting Pins (SMP3B). A Cy3-labeled oligonucleotide is included as a spotting control and one capture oligonucleotide is included in the subarray to be used to capture a TAMRA-labeled hybridization control. The remaining amino-reactive groups on the slides are blocked with ethanolamine according to the manufacturer's instructions. 30 
Genotyping on microarrays
The PCR products from each individual are combined and concentrated to about 30 ml using spin dialysis or by another suitable method. An aliquot of 14 ml of the concentrated PCR product is treated with 0.5 U/ml Exonuclease I and 0.1 U/ml shrimp alkaline phosphatase in 5.6 mM MgCl 2 and 50 mM TrisHCl, pH 9.5, in a total volume of 21 ml at 371C for 60 min, followed by inactivation of the enzymes at 951C for 15 min in a thermocycler. Each minisequencing reaction mixture contains 21 ml of enzyme-treated PCR product, the tagged minisequencing primers at 5.0 nM each, 0.18 mM of fluorescently labeled TexasRed-ddATP, TAMRA-ddCTP, R110-ddGTP, and 0.27 mM Cy5-ddUTP, 0.017% Triton X-100, 17 mM Tris-HCl, pH 9.5 and 0.07 U/ml of Thermo Sequenaset DNA Polymerase. The total minisequencing reaction volume is 30 ml and the cyclic reactions are performed in a thermocycler for 99 cycles of 951C and 551C for 20 s each.
The arrayed slides are preheated to 421C in a reaction rack with a silicon rubber grid forming 14 separate reaction chambers on each slide. 31, 32 The hybridization mixtures, containing 30 ml of minisequencing reaction product and 0.4 nM TAMRA-labeled hybridization control oligonucleotide in 44 ml of 900 mM NaCl, 90 mM sodium citrate, pH 7.0, are added to each reaction chamber on the slide. The hybridization time is 2.0-2.5 h at 421C, after which the slides are rinsed briefly with 600 mM NaCl and 60 mM sodium citrate, pH 7.0, at room temperature. The slides are then washed twice for 5 min with 300 mM NaCl and 30 mM sodium citrate, pH 7.0 and 0.1% SDS preheated to 421C and twice for 1 min with 30 mM NaCl and 3 mM sodium citrate, pH 7.0, at room temperature. Finally, the slides are dried by centrifugation for 5 min at 500 r.p.m.
Signal detection and genotype assignment
Fluorescence signals are measured with an array scanner equipped with four lasers. We use a ScanArray s 5000 instrument with the excitation lasers Blue Argon 488 nm, Green HeNe 543.8 nm, Yellow HeNe 594 nm and Red HeNe 632.8 nm. The signal intensities are measured with the QuantArray s analysis 3.1 software. Background correction is carried out by measuring fluorescence intensities from 10 spots below the subarray and by subtracting the average background from every spot in the same subarray. The genotypes are determined by calculating the ratio (R) between the signal intensities of the two alleles for each SNP, for example, by using a Microsoft Excelt macro.
Genotyping using solid-phase minisequencing Four 10 ml aliquots of the individual PCR product and 40 ml of phosphate-buffered saline with 0.1% Tween 20 are added to streptavidin-coated microtiter plate wells and incubated for 1.5 h at 371C with shaking. The plates are washed six times with 40 mM Tris-HCl, pH 8.8, 1 mM EDTA, 50 mM NaCl and 0.1% Tween 20 in a plate washer, after which the nonbiotinylated strand of the PCR product is removed by denaturation with 60 ml 50 mM NaOH for 3 min. The microtiter plates are then washed as above before adding 50 ml of minisequencing reaction mix containing DNA polymerase buffer, 0. 
Determination of SNP allele fractions and proportion of donor cells
The samples are analyzed in duplicate and the average signals are used. The signal ratio (R) between the two possible [ 3 H]dNTPs to be incorporated at each SNP site is used. For each SNP, the signal ratios in the donor and patient samples prior to SCT and the follow-up samples after SCT are compared to the corresponding signal ratios in heterozygous samples (R het ) where the two SNP alleles are present in equal amounts. Using R het as reference value for the quantitative determination, the SNP allele fractions are calculated according to the formula: The determination of the proportion of donor cells in the follow-up samples is based on the allele fraction of the unique SNP that distinguishes between the donor and the recipient in each pair. The signal from the unique SNP allele represents all the contribution from the differing individual in the case of homozygosity, but only half in the case of heterozygosity. In the latter case, the proportion of donor cells is determined by multiplying the fraction of the unique SNP allele by two.
Time requirement
The total time required for the PCR amplification is about 3 h, which includes a hands-on time of approximately 30 min, provided that DNA has been extracted and that premade master mixes are used. The minisequencing procedure for one microarray slide with up to 14 samples requires a total time of 7 h including a hands-on time of approximately 3 h. Scaling up to process three microarray slides in parallel does not increase the required time, except for the processing of data, which will requires approximately 1 h per microarray slide. For minisequencing in a microtiter plate format, the total time for processing one microtiter plate with 12 samples is 4.5 h including a hands-on time of 1 h.
Sensitivity
The sensitivity for detecting an SNP allele present as a minority in a mixed DNA sample ranges from 0.5 to 2.5% depending on the SNP marker ( Figure 3 in the Main Article). The detection limit has been determined in experiments using mixtures of DNA with known genotypes and with a total amount of 10 ng of genomic DNA in each reaction. The sensitivity of detection of the minority allele for an SNP marker is influenced by the nucleotide sequence flanking the SNP, which affects the specificity of nucleotide incorporation by the DNA polymerase. The sensitivity is also influenced by the specific activity and number of [ 
Reproducibility and accuracy
The mean values for the coefficients of variance for the points in the standard curves ( Figure 3 in the Main Article) are 8%, and vary between 6 and 10% between the three SNPs. The method is highly accurate with a linear relationship between the logarithm of the minsequencing ratios and the logarithm of ratios between the two alleles subjected to the analysis, with regression coefficients (R 2 ) higher than 0.99 for the standard curves.
Cost of the assay
The overall cost per analysis depends on the total number of samples analyzed in parallel. The approximate costs given here are the costs for one sample processed in parallel with 12 samples. The reagent cost for a single PCR is 0.4 Euro. For the minisequencing on microarrays, the reagent costs per sample are 4.4 Euro (51 SNP genotypes in duplicate in both DNA polarities). For the minisequencing in the microtiter plate format, the cost per sample is 1 Euro (one SNP genotype in duplicate). Laboratory equipment and staff are not included in the calculation.
Troubleshooting
For minisequencing on microarrays
False-positive signals:
Hairpin loop secondary structures involving the 3 0 -end of a primer can give rise to template-independent primer extension. To avoid this problem, evaluate the primer sequences with a primer design program that predicts secondary structures.
